Search

Your search keyword '"ZHAO, Jing"' showing total 183 results
Start Over Author "ZHAO, Jing" Journal medicine
183 results on '"ZHAO, Jing"'

3. Therapeutic experience of a pancreatic mixed serous neuroendocrine neoplasm invading peripancreatic vessels: A case report

Author

Zhang, Zongming, Liu, Limin, Li, Youwei, Liu, Zhuo, Zhang, Chong, Zhao, Yue, Zhu, Mingwen, Wan, Baijiang, Deng, Hai, Xie, Xiyuan, Tian, Kun, Guo, Zhentian, Yang, Haiyan, Liao, Jiahong, Zhu, Hongyan, Liu, Lili, Wang, Man, Ma, Xiaoting, Liu, Tiantian, Huang, Niuniu, Gao, Yujiao, Zhao, Jing, Liao, Fang, Li, Fengyuan, Wang, Xueting, Yuan, Ruijiao, Liu, Xinying, and Chang, Lidan

Published
2022
Full Text
View/download PDF

35. Association between Helicobacter pylori infection and the risk of colorectal cancer

Author

Xinyu Hao, Zuo Yuling, Mingjiang Bie, Zhao Jing, Baoning Wang, and Chunyan Xu

Subjects
Adult, Male, medicine.medical_specialty, Helicobacter pylori infection, Colorectal cancer, MEDLINE, Subgroup analysis, colorectal cancer, Helicobacter Infections, 03 medical and health sciences, 0302 clinical medicine, systematic review, Risk Factors, Internal medicine, medicine, Odds Ratio, Humans, 030212 general & internal medicine, subgroup analysis, Aged, biology, Helicobacter pylori, business.industry, General Medicine, Odds ratio, Middle Aged, medicine.disease, biology.organism_classification, Confidence interval, meta-analysis, 030220 oncology & carcinogenesis, Meta-analysis, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, Female, heterogeneity, business, Colorectal Neoplasms, Systematic Review and Meta-Analysis, Research Article
Abstract

Supplemental Digital Content is available in the text, Background: The existing evidence on the relationship between Helicobacter pylori infection and the risk of colorectal cancer is inconsistent. We conducted a systematic review with a meta-analysis to explore this relationship and to determine whether the relationship varies according to the study characteristics. Methods: We searched the PubMed, OVID, EMBASE database, and the reference lists of pertinent articles published up to October 2019 by 2 researchers independently. Summary odds ratios (OR) with their 95% confidence intervals (CIs) were estimated using a random-effects model. Results: Forty seven studies including 17,416 cases of colorectal cancer (CRC) and 55,811 cases of control were included. Overall, H. pylori infection was associated with an increased risk of CRC (OR = 1.70 95% CI 1.64–1.76, I2 = 97%), although there was significant heterogeneity among the studies. Subgroup analysis revealed that the positive correlation might vary by the design of study conducted. Conclusion: This meta-analysis demonstrates a positive association between H. pylori infection and the risk of colorectal cancer.

Published
2020

39. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients

Author

Dao Xing-Yuan, Li Fang, Kong Fan-Guo, Yang Ting-Ting, Peng Tao, Qi Lin, Qi Hao-Liang, Shang Yan-Sheng, Yin Shou-Xin, Liu Man, Huang Jia-Guo, Zhao Jing, and Han Shuai

Subjects
medicine.medical_specialty, Endoscopic retrograde cholangiopancreatography, medicine.diagnostic_test, business.industry, medicine.drug_class, Incidence (epidemiology), General Medicine, medicine.disease, Gastroenterology, Anti-inflammatory, law.invention, 03 medical and health sciences, 0302 clinical medicine, Diclofenac, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Meta-analysis, Relative risk, Internal medicine, Medicine, Pancreatitis, 030212 general & internal medicine, business, medicine.drug
Abstract

Background 100 mg rectal nonsteroidal anti-inflammatory drugs (NSAIDs) and pancreatic stents both significantly reduce the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Direct comparison of randomized controlled trials (RCTs) between them in high-risk patients is absent. We conducted this network meta-analysis to indirectly compare the efficacies of 100 mg rectal NSAIDs and pancreatic stents in preventing post-ERCP pancreatitis (PEP) in high-risk patients and help us decide which is preferred in clinical practice. Methods A comprehensive search was done to identify RCTs published in English full-text. Interventions included 100 mg rectal NSAIDs (diclofenac or indomethacin) and pancreatic stents. Only studies with high-risk patients of PEP were included. Meta-analyses of NSAIDs and pancreatic stents were conducted respectively. A network meta-analysis using the Bayesian method was performed. Results We included 14 RCTs, 8 on pancreatic stents and 6 on 100 mg rectal NSAIDs in high-risk patients. There was no direct comparison between them. After excluding an outlier study on NSAIDs (n = 144), meta-analyses showed they both significantly and statistically reduced the incidence of PEP in high-risk patients (pancreatic stents: n = 8 studies, random-effects risk ratio (RR)0.41, 95%CI 0.30-0.56, I = 0%; NSAIDs: n = 5 studies, random-effects RR 0.37, 95%CI 0.25-0.54, I = 0%). And network meta-analysis showed efficacy of 100 mg rectal NSAIDs was equal to pancreatic stents (random-effects RR 0.94, 95%CI 0.50-1.8). Conclusions The efficacy of 100 mg rectal NSAIDs (diclofenac or indomethacin) seems equally significant to pancreatic stents in preventing PEP in high-risk patients. Considering the cost-effectiveness and safety, 100 mg diclofenac or indomethacin may be preferred.

Published
2020

44. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A network meta-analysis.

Author

Yin Shou-xin, Han Shuai, Kong Fan-guo, Dao Xing-yuan, Huang Jia-guo, Peng Tao, Qi Lin, Shang Yan-sheng, Yang Ting-ting, Zhao Jing, Li Fang, Qi Hao-liang, Liu Man, Shou-Xin, Yin, Shuai, Han, Fan-Guo, Kong, Xing-Yuan, Dao, Jia-Guo, Huang, Tao, Peng, and Lin, Qi

Published
2020
Full Text
View/download PDF

50. Thoracic outlet syndrome (TOS)

Author

Zhang, Weiqiang, primary, Pei, Yingxin, additional, Liu, Keqiang, additional, Tan, Jian, additional, Ma, Jingbo, additional, and Zhao, Jing, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results